Management of cardiovascular risk factors in patients with ANCA‐associated vasculitis

201734 citationsJournal Article

Authors

Carsten Bramlage · IPPMed (Germany)

Juliane Kröplin · University of Göttingen

Manuel Wallbach · University of Göttingen

Joan Minguet · IPPMed (Germany)

Katherine Smith · Institute of Agrifood Research and Technology

Stephan Lüders · St. Josefs-Hospital Cloppenburg

Joachim Schrader

Abstract

Patients with AAV are at high CV risk, but management of the associated risk factors is poor. In addition to improving the treatment of hypercholesterolemia and hypertension, lipoprotein(a) is a further potential target for reducing CV risk in individuals with AAV.

Topics & Keywords

Vasculitis and related conditions Atherosclerosis and Cardiovascular Diseases Coagulation, Bradykinin, Polyphosphates, and Angioedema

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Evaluation in Clinical Practice

Volume 23, Issue 4, pp. 747-754

DOI: 10.1111/jep.12709

Field-Weighted Citation Impact: 2.45